New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 21, 2014
09:36 EDTARIAARIAD names Sarissa Capital's Denner to board
ARIAD Pharmaceuticals announced earlier today the appointment of Alexander Denner, Ph.D. to a two-year term on the company’s board, effective immediately. Dr. Denner serves as the chief investment officer and founding partner of Sarissa Capital Management. Previously, Dr. Denner served as a senior managing director at Icahn Capital.
News For ARIA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 22, 2015
07:38 EDTARIAARIAD appoints DesRosier as Chief Legal and Administrative Officer
Subscribe for More Information
January 20, 2015
07:36 EDTARIAARIAD says EC endorses final opinion adopted by CHMP on Iclusig
Subscribe for More Information
January 14, 2015
07:20 EDTARIAARIAD sees product revenues reaching over $400M in 2018
For 2014, sees product and license revenue at $100M, R&D expenses $120M. For 2015, plans to accelerate Iclusig sales in U.S. and Europe, initiate key Iclusig trials, secure broad partnership for brigatinib, file for Iclusig approval in Japan with Otsuka, file IND for new development candidate AP32788. Comments from slides that will be presented at the JP Morgan Healthcare Conference.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use